Below are the best information and knowledge on the subject new treatment for dry macular degeneration 2020 compiled and compiled by our own team alltopus:
1. Potential way to halt blinding macular degeneration identified: Scientists find unexpected connection between 2 main forms of AMD
Date Submitted: 08/02/2020 10:38 AM
Average star voting: 5 ⭐ ( 18483 reviews)
Summary: It would be the first treatment for dry age-related macular degeneration and could significantly improve treatment for wet AMD.
Match with the search results: One promising new treatment, for wet AMD, involves retinal gene therapy, as an alternative to monthly eye injections. The goal of ……. read more
2. Researchers make a breakthrough in the quest for an AMD cure
Date Submitted: 08/11/2019 12:58 AM
Average star voting: 5 ⭐ ( 36154 reviews)
Summary: Age-related macular degeneration (AMD), which leads to a loss of central vision, is the most frequent cause of blindness in adults 50 years of age or older, affecting an estimated 196 million people worldwide. There is no cure, though treatment can slow the onset and preserve some vision.
Match with the search results: A promising new method is a tiny, refillable drug reservoir that is surgically implanted in the eye, just under the eyelid. The device is ……. read more
3. Age-Related Macular Degeneration Revisited: From Pathology and Cellular Stress to Potential Therapies
Date Submitted: 05/17/2019 12:34 PM
Average star voting: 3 ⭐ ( 91486 reviews)
Summary: Age-related macular degeneration (AMD) is a neurodegenerative disease of the aging retina, in which patients experience severe vision loss. Therapies available to patients are limited and are only effective in a sub-population of patients. Future comprehensive clinical care depends on identifying new therapeutic targets and adopting a multi-therapeutic approach. With this goal in mind, this review examines the fundamental concepts underlying the development and progression of AMD and re-evaluates the pathogenic pathways associated with the disease, focusing on the impact of injury at the cellular level, with the understanding that critical assessment of the literature may help pave the way to identifying disease-relevant targets. During this process, we elaborate on responses of AMD vulnerable cells, including photoreceptors, retinal pigment epithelial cells, microglia, and choroidal endothelial cells, based on in vitro and in vivo studies, to select stressful agents, and discuss current therapeutic developments in the field, targeting different aspects of AMD pathobiology.
Match with the search results: Susvimo is the first wet AMD treatment in 15 years to provide an alternative to standard-of-care eye injections needed as often as once a month….. read more